| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/23/1991 | US5010015 Plasmid capable of multiplying in bacillus, regulation and secretion signal sequences of the amylase gene and the dna sequence encoding for the protein or polypeptide |
| 04/23/1991 | US5010000 Method for the preparation of a selected protein or a part thereof in Bacillus strain bacteria |
| 04/23/1991 | US5009889 Treatment of dysfunctional vascular endothelium using activated protein C |
| 04/23/1991 | CA1283500C Thiopeptolide substrates for vertebrate collagenase |
| 04/23/1991 | CA1283499C Peptides |
| 04/23/1991 | CA1283359C Compositions of neocarzinostatin derivative for non-injection administration |
| 04/23/1991 | CA1283358C Insulin preparation |
| 04/23/1991 | CA1283357C Thrombosis treatment with fibrinolytics and prostacyclins |
| 04/23/1991 | CA1283356C Pharmaceutical compositions of microbially produced interleukin-2 |
| 04/21/1991 | WO1991005805A1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 04/21/1991 | WO1991005568A1 Materials and methods for the treatment of foreign tissue |
| 04/21/1991 | WO1991005546A1 Solid tumor treatment method and composition |
| 04/21/1991 | WO1991005545A1 Liposome microreservoir composition and method |
| 04/21/1991 | CA2069342A1 Materials and methods for the treatment of foreign tissue |
| 04/21/1991 | CA2028086A1 Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
| 04/21/1991 | CA2028082A1 Modified heparin cofactor ii |
| 04/21/1991 | CA2028045A1 Infectious bronchitis virus vaccine |
| 04/21/1991 | CA2028024A1 Tumor-associated antigen |
| 04/20/1991 | WO1991006005A1 Method of assaying d-vanillylmandelic acid, and reagent and kit therefor |
| 04/20/1991 | CA2027964A1 External skin preparation |
| 04/19/1991 | WO1991005565A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b) |
| 04/19/1991 | CA2070393A1 Biosynthetic constructs of tgf-beta |
| 04/18/1991 | WO1991005059A1 Monoclonal antibody recognizing a pre-s1 region of the large envelope protein of the b hepatitis virus |
| 04/18/1991 | WO1991005048A1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use |
| 04/18/1991 | WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 04/18/1991 | WO1991005046A1 Granulocyte-colony stimulating factor receptors |
| 04/18/1991 | WO1991005045A1 PORCINE LACTOFERRIN AMINO ACID AND cDNA SEQUENCE |
| 04/18/1991 | WO1991005041A1 Erythroid-specific gene expression system |
| 04/18/1991 | WO1991005040A1 Cloned genes for human dopamine d2 receptors and cell lines expressing same |
| 04/18/1991 | WO1991005038A1 Blood-brain barrier model |
| 04/18/1991 | WO1991004985A1 Dehydrodidemnin b |
| 04/18/1991 | WO1991004755A1 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 04/18/1991 | WO1991004750A1 Method of treatment |
| 04/18/1991 | WO1991004749A1 Method of treating infectious bursal disease virus |
| 04/18/1991 | WO1991004748A1 INHIBITING TRANSFORMING GROWTH FACTOR β TO PREVENT ACCUMULATION OF EXTRACELLULAR MATRIX |
| 04/18/1991 | WO1991004743A1 Stabilized aqueous formulations of small peptides |
| 04/18/1991 | WO1991004728A2 Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome |
| 04/18/1991 | WO1991004673A1 Feed additive for poultry, poultry feed and method of poultry feeding |
| 04/18/1991 | WO1991004316A3 Ciliary neurotrophic factor |
| 04/18/1991 | WO1991002805A3 Recombinant retroviruses delivering vector constructs to target cells |
| 04/18/1991 | WO1990015076A3 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
| 04/18/1991 | DE3933850A1 Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins Cytolysis inhibitor (ZLI), these a blood plasma protein encoding DNA sequence, and a plasmid, a host organism and a method for obtaining this protein |
| 04/18/1991 | CA2027725A1 Use of a polypeptide with human interleukin-2 activity for preparation of pharmaceutical compositions used in leukemia treatment |
| 04/18/1991 | CA2027723A1 Use of glycoproteins extracted from gram-negative bacteria to produce cosmetic or dermatologic compositions, and compositions containing them |
| 04/17/1991 | EP0423077A1 Tripeptide compounds and their pharmaceutical use as immunomodulators |
| 04/17/1991 | EP0422938A1 Fibrinogen receptor antagonists |
| 04/17/1991 | EP0422937A1 Fibrinogen receptor antagonists |
| 04/17/1991 | EP0422769A1 Albumin purification |
| 04/17/1991 | EP0422697A1 A consensus leukocyte interferon and a gene encoding it |
| 04/17/1991 | EP0422490A2 Triglycerides containing saturated fatty acids having 20 to 24 carbon atoms useful in lowering blood cholesterol levels |
| 04/17/1991 | EP0422339A1 Tumor necrosis factor (TNF) inhibitor and method for obtaining the same |
| 04/17/1991 | EP0422217A1 Human recombinant placental ribonuclease inhibitor and method of production |
| 04/17/1991 | EP0422215A1 Antibacterial and antimalarial peptides |
| 04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
| 04/17/1991 | EP0422181A1 Method and means for inducing, resp., preventing constriction of the pupil in the eye |
| 04/17/1991 | EP0422140A1 Thyroleberin as immunomodulator and lipid regulator |
| 04/17/1991 | EP0422115A1 Identification of human t-lymphocyte epitopes in pathogens for vaccine development |
| 04/17/1991 | EP0422104A1 Angiogenic potentiating peptides which potentiate angiogenic factors |
| 04/17/1991 | EP0422043A1 Bispecific antibodies |
| 04/17/1991 | EP0422010A1 Combination therapy of il-2 and dtic for the treatment of melanoma |
| 04/17/1991 | EP0236307B1 Antihypertensive agents, pharmaceutical compositions containing them and processes for the preparation of the agents and compositions |
| 04/17/1991 | EP0174999B1 Method for improving expression and method thereto |
| 04/17/1991 | CN1050721A Radiolabeled anticoagulant peptides |
| 04/17/1991 | CN1050720A Anticoagulant peptides |
| 04/17/1991 | CA2267658A1 Use of stem cell factor polypeptide to stimulate growth of epithelial cells |
| 04/17/1991 | CA2267643A1 Use of stem cell factor polypeptide as an anti-hematopoietic disorder agent |
| 04/17/1991 | CA2267626A1 Use of stem cell factor polypeptide to stimulate growth of stromal cells |
| 04/17/1991 | CA2027637A1 N-acetylmuramidase m1 |
| 04/16/1991 | US5008400 Bicyclic aminoacids as intermediates |
| 04/16/1991 | US5008374 IL-1α derivatives and drugs |
| 04/16/1991 | US5008371 Biologically active polypeptide and use thereof |
| 04/16/1991 | US5008288 Skeletal & heat muscle disorders |
| 04/16/1991 | US5008284 Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation |
| 04/16/1991 | US5008273 Amino acid derivatives and their pharmaceutical use |
| 04/16/1991 | US5008257 Brain-specific drug delivery |
| 04/16/1991 | US5008251 Method of treating autism |
| 04/16/1991 | US5008246 Novel peptides suppressing the function of the immune system, pharmaceutical compositions containing them and process for preparing same |
| 04/16/1991 | US5008245 Novel peptidyl carbamate inhibitors of the enzyme elastase |
| 04/16/1991 | US5008244 Method for increasing fertility in animals |
| 04/16/1991 | US5008243 Controlling metabolism and/or production of prostaglandins |
| 04/16/1991 | US5008242 Treatment of inflammation using 1-antichymotrypsin |
| 04/16/1991 | US5008241 Amino acid replacements provide increased charge at neutral pH and stability at acid pH |
| 04/16/1991 | US5008240 Polypeptide with amino acid sequence of cartilage inducing factor A or B |
| 04/16/1991 | US5007925 Prosthetic devices coated with polypeptides with type IV collagen activity |
| 04/16/1991 | CA1283073C Adsorbent for purification of blood coagulation factor viii and process for purification of blood coagulation factor viii using the same |
| 04/16/1991 | CA1283072C Process for the isolation and separation of lysozyme and avidin from eggwhite |
| 04/16/1991 | CA1283048C Therapeutic agent for treating hematopoietic diseases |
| 04/16/1991 | CA1283047C Stabilized plasminogen activator precursor and method of producing the same |
| 04/16/1991 | CA1283046C Tumor necrosis factor formulation |
| 04/14/1991 | WO1991005797A1 Methods and compositions for healing bone |
| 04/14/1991 | WO1991005796A1 Carboxyalkyl dipeptide inhibitors of endopeptidases |
| 04/14/1991 | WO1991005754A2 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/14/1991 | WO1991005563A1 Therapeutic decapeptides |
| 04/14/1991 | CA2069312A1 Carboxyalkyl dipeptide inhibitors of endopeptidases |
| 04/14/1991 | CA2067505A1 Methods and compositions for healing bone |
| 04/14/1991 | CA2044162A1 Long-chained fatty alcohol derivatives, their applications, specifically as cytotrphic and cytoprotecting molecules, and pharmaceutical compounds containing same |
| 04/14/1991 | CA2044137A1 Therapeutic decapeptides |
| 04/14/1991 | CA2027315A1 Fibrinogen receptor antagonists |
| 04/14/1991 | CA2027314A1 Fibrinogen receptor antagonists |
| 04/13/1991 | WO1991005801A1 Dopamine releasing protein |